Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area

Saved in:
Bibliographic Details
Published in:Dermatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871565586801098753
collection WordPress RSS
FRELIP Feed Integration
container_title Dermatology and Therapy
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:106079
institution FRELIP
journal_source_facet Dermatology and Therapy
last_indexed 2026-07-24T03:33:51.582Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_alt Resultados del tratamiento con lebrikizumab después del cambio de dupilumab en dermatitis atópica moderada a grave que afecta el área de cabeza y cuello
Résultats du traitement par lebrikizumab après passage du dupilumab dans la dermatite atopique modérée à sévère impliquant la région de la tête et du cou
Resultados do Tratamento com Lebrikizumabe após Troca de Dupilumabe na Dermatite Atópica Moderada a Grave Envolvendo a Região da Cabeça e Pescoço
title_auth Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_es_txt Resultados del tratamiento con lebrikizumab después del cambio de dupilumab en dermatitis atópica moderada a grave que afecta el área de cabeza y cuello
title_fr_txt Résultats du traitement par lebrikizumab après passage du dupilumab dans la dermatite atopique modérée à sévère impliquant la région de la tête et du cou
title_full Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_fullStr Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_full_unstemmed Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_pt_txt Resultados do Tratamento com Lebrikizumabe após Troca de Dupilumabe na Dermatite Atópica Moderada a Grave Envolvendo a Região da Cabeça e Pescoço
title_short Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
title_sort treatment outcomes of lebrikizumab after switching from dupilumab in moderate-to-severe atopic dermatitis involving the head and neck area
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://link.springer.com/article/10.1007/s13555-026-01863-2